192 results
DEFA14A
INVA
Innoviva Inc
29 Apr 24
Additional proxy soliciting materials
5:30pm
to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important … make this request on or before June 5, 2024.
Your control number
Have the 12 digit control number located in the box above available when you access
8-K
EX-10.2
INVA
Innoviva Inc
20 May 21
Innoviva Announces Strategic Repurchase of GSK’s Equity Stake
5:12pm
of shares of the Investor held by Glaxo Group Limited and desires to access capital from its Capital Account to fund in part the transaction. In order … to provide the Investor access to the necessary capital for such transaction, the General Partner shall make a distribution to the Investor
DEFA14A
INVA
Innoviva Inc
5 May 21
Additional proxy soliciting materials
4:17pm
to the start time in order to leave ample time to confirm the internet connection is sufficient to access the site and to allow sufficient time to log … they access the meeting can click on the “Support” link on the meeting platform site. Stockholders are encouraged to learn more about the virtual
8-K
EX-99.1
INVA
Innoviva Inc
1 Dec 14
Anoro® Ellipta® (umeclidinium/vilanterol) to be reimbursed in Australia for Chronic Obstructive Pulmonary Disease
12:00am
Hospital said he welcomed the improved access to new treatments that results from PBS reimbursement.
“I certainly welcome better access to effective
DEFA14A
INVA
Innoviva Inc
17 May 23
Additional proxy soliciting materials
5:18pm
electronically together with the Proxy Statement and our 2022 annual report at http://investor.inva.com/sec-filings. You may also access
8-K
EX-10.1
r0tdxr 7ae34w
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
DEFA14A
9dp z6rum6
31 Mar 20
Additional proxy soliciting materials
4:12pm
8-K
EX-99.1
s5v6 mxbn780
14 Sep 22
Regulation FD Disclosure
5:22pm
8-K
EX-10.1
avchk2rqniq8
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
8-K
EX-99.1
1x5c pllx9z
7 Apr 22
Regulation FD Disclosure
5:09pm
8-K
EX-99.1
6nuhd2kwt1ldaqj6gw08
23 Aug 22
Other Events
4:08pm
SC TO-C
EX-2.1
k9yf21z
11 Jul 22
Information about tender offer
3:46pm
8-K
EX-2.1
4x7cylqf
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am